Lavender Bina Cendikia Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 5.1× Lavender Bina Cendikia Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 2.96M). Which is the better fit depends on your goals.
| BMBL | DKHH | |
|---|---|---|
Market Cap | 30.9B | 158.12B |
Volume | 2.96M | 8.21M |
Lot | 29.64K | 82.15K |
Turnover | 88.75M | 515.2M |
Average Price | 29.94 | 62.72 |
Value | 88.75M | 515.2M |
Indicative Equilibrium Price | 30 | 63 |
Indicative Equilibrium Volume | 1 | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Read more on BMBL →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →